Want to see ARDT full AI Analyst Report?
ARDT Stock Chart & Stats
$9.91
$0.02(0.12%)
At close: 4:00 PM EST
$9.91
$0.02(0.12%)
Day’s Range― - ―
52-Week Range$7.71 - $15.48
Previous CloseN/A
Volume15.92K
Average Volume (3M)630.51K
Market Cap
$1.45B
Enterprise Value$2.98B
Total Cash (Recent Filing)$609.69M
Total Debt (Recent Filing)$2.29B
Price to Earnings (P/E)10.6
Beta0.57
Next Earnings
Aug 19, 2026EPS Estimate
0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.95
Shares Outstanding143,350,040
10 Day Avg. Volume536,297
30 Day Avg. Volume630,513
Financial Highlights & Ratios
PEG Ratio-0.23
Price to Book (P/B)0.74
Price to Sales (P/S)0.20
P/FCF Ratio4.81
Enterprise Value/Market Cap2.06
Enterprise Value/Revenue0.46
Enterprise Value/Gross Profit0.93
Enterprise Value/Ebitda5.89
Forecast
1Y Price Target
$12.75Price Target Upside28.66% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)1.12
Revenue Forecast (FY)$6.53B
Bulls Say, Bears Say
Bulls Say
Reduced Leverage / Stronger Balance SheetMaterial deleveraging is durable tailwind: debt-to-equity fell from ~3.6–3.7x (2022–23) to ~0.70x TTM, expanding financial flexibility. Lower leverage reduces interest burden, supports investment or M&A, and improves resilience to reimbursement or volume shocks over the next several quarters.
IMPACT Program Driving Structural Cost SavingsIMPACT is delivering recurring operational savings ($55M target) that materially bolster margins. Demonstrated execution (labor, vendor consolidation, process changes) creates a sustainable cost base, improving margin resiliency and funding reinvestment in higher‑return ambulatory and tech initiatives.
Consistent Revenue Growth And Ambulatory ExpansionMulti-year top-line growth combined with ambulatory expansion (urgent cares, ASCs, virtual care partnership) supports scale and higher‑margin mix. Durable revenue momentum underpins margin leverage potential and provides a base to absorb cost pressures over the coming 2–6 months.
Bears Say
Thin, Volatile ProfitabilityNet margins near ~2% and inconsistent operating returns create limited earnings buffer. Thin profitability makes results sensitive to reimbursement shifts, payor mix, malpractice or professional fee increases, and limits ability to self-fund growth without sustained margin improvement.
Moderate Cash Conversion And FCF SofteningFCF at roughly half of net income and recent TTM decline constrain internal funding for capex and expansion. Moderate cash conversion increases reliance on liquidity or debt for growth initiatives and makes the company more sensitive to working capital swings over the medium term.
Exchange / Payer‑mix HeadwindStructural shifts in exchange enrollment and metal-tier mix increase patient cost-sharing and reduce revenue throughput. A persistent ~$35M EBITDA drag elevates earnings volatility and revenue risk, complicating margin continuity and planning over the next several quarters.
Ardent Health Partners, Inc. News
ARDT FAQ
What was Ardent Health Partners, Inc.’s price range in the past 12 months?
Ardent Health Partners, Inc. lowest stock price was $7.71 and its highest was $15.48 in the past 12 months.
What is Ardent Health Partners, Inc.’s market cap?
Ardent Health Partners, Inc.’s market cap is $1.45B.
When is Ardent Health Partners, Inc.’s upcoming earnings report date?
Ardent Health Partners, Inc.’s upcoming earnings report date is Aug 19, 2026 which is in 39 days.
How were Ardent Health Partners, Inc.’s earnings last quarter?
Ardent Health Partners, Inc. released its earnings results on May 05, 2026. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.191 by $0.089.
Is Ardent Health Partners, Inc. overvalued?
According to Wall Street analysts Ardent Health Partners, Inc.’s price is currently Undervalued.
Does Ardent Health Partners, Inc. pay dividends?
Ardent Health Partners, Inc. does not currently pay dividends.
What is Ardent Health Partners, Inc.’s EPS estimate?
Ardent Health Partners, Inc.’s EPS estimate is 0.22.
How many shares outstanding does Ardent Health Partners, Inc. have?
Ardent Health Partners, Inc. has 143,350,040 shares outstanding.
What happened to Ardent Health Partners, Inc.’s price movement after its last earnings report?
Ardent Health Partners, Inc. reported an EPS of $0.28 in its last earnings report, beating expectations of $0.191. Following the earnings report the stock price went down -7.502%.
Which hedge fund is a major shareholder of Ardent Health Partners, Inc.?
Currently, no hedge funds are holding shares in ARDT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ardent Health Partners, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.75 (28.66% Upside)
$12.75 (28.66% Upside)
Blogger Sentiment
Bullish
ARDT Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 699.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $186.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 6.3%
Last 30 Days ▲ 7.9%
Last 30 Days ▲ 7.9%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.36%
12-Months-Change
Fundamentals
Return on Equity
9.08%
Trailing 12-Months
Asset Growth
6.95%
Trailing 12-Months
Company Description
Ardent Health Partners, Inc.
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
ARDT Company Deck
ARDT Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed predominantly positive operational and financial momentum: solid top-line growth (+7% revenue), strong adjusted EBITDA improvement (+26%, or +15% excluding a one-time investment gain), meaningful margin expansion (110 bps), demonstrable cost and labor discipline (contract labor down >40%, SW&B per AA improvements), and healthy liquidity and leverage metrics. Management acknowledged near-term volume headwinds from weather and lighter flu, exchange-related revenue pressure (~$35M estimated headwind), higher professional fees and medical malpractice premium increases, and ongoing denial-management work. On balance, the positive execution against the IMPACT program, margin gains, cash/liquidity strength, and disciplined growth initiatives outweigh the noted challenges.View all ARDT earnings summariesARDT Stock 12 Month Forecast
Average Price Target
$12.75
▲(28.66% Upside)
Technical Analysis
Acadia Healthcare
―
Brookdale Senior Living
―
National Healthcare
―
Select Medical
―
Aveanna Healthcare Holdings
―
Ownership Overview
2.76% Insiders
3.72% Mutual Funds
65.08% Other Institutional Investors
25.56% Public Companies and
Individual Investors